TOTECT^® (dexrazoxane for injection) is the only FDA-approved treatment for extravasation from intravenous anthracycline chemotherapy, the accidental leakage of chemotherapy drugs into surrounding tissue.

Totect^® provides rapid patient care to avoid interruption of chemotherapy treatments, multiple surgical procedures, wound care, physical therapy, loss
of work, and potential legal consequences.

For product safety and prescribing information please go to:
http://www.totect.com